| Israel | Turkey | Austria | |
| Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | from $42,000 | from $22,500 | from $40,000 |
| Chemotherapy for breast cancer | from $22,500 | from $1,200 | from $15,000 |
| Small intestine resection | - | from $13,608 | from $25,000 |
| Radiation therapy for colorectal cancer | - | from $7,000 | from $12,000 |
| Radiation therapy for bowel cancer | - | from $5,800 | from $6,867 |
No hidden fees – just official clinic prices. Pay at the clinic for Small intestine cancer treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Small intestine cancer treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Small intestine cancer treatment journey.
Dr. Arnon Nagler is a hematologist at Sheba Medical Center in Israel. He is a professor at Tel Aviv University and a renowned transplant expert. Dr. Nagler founded Israel’s first public cord blood bank. He also performed the first cord blood transplantations in the country. He completed postdoctoral training at Stanford University and is board-certified in hematology.
Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center in Israel. He was recognized by Forbes as one of the country's top physicians. Prof. Nachmany specializes in robotic surgery for the liver, pancreas, and bile ducts. He focuses on treating gastrointestinal neuroendocrine tumors using minimally invasive techniques.
Dr. Almog Ben Yaacov is a senior surgical oncologist at Sheba Medical Center. He has performed over 200 HIPEC procedures for complex abdominal cancers. He focuses on treating gastric cancer, sarcoma, and colorectal malignancies. Dr. Ben Yaacov holds board certifications in both General Surgery and Surgical Oncology.
Dr. Amit Tirosh is the Head of the Neuroendocrine Tumors (NET) Service at Sheba Medical Center. He is an international authority on von Hippel–Lindau (VHL) disease and hereditary tumor syndromes. Dr. Tirosh contributed to global clinical guidelines for VHL management. He also leads the Endocrine Oncology Bioinformatics Lab at Sheba.